Awarded Contractocds-h6vhtk-036b0f

NHS North of England Branded Medicines Tranche A & Annual Tranche

NHS Framework for North of England Branded Medicines - Tranche A and Annual Tranche.<br/>Offer reference number: CM/PHR/20/5606<br/>CM/PHR/20/5606/01 - NHS Framework for North of England Branded Medicines - Tranche A. Period of framework: 1 March 2023 to 28 February 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months<br/>CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche. Period of framework: 1 March 2023...

Buyer

NHS England

Value

£653,653,647

Published

15 Mar 2023

Closes

24 Oct 2022

Procurement details

Source

Find a Tender

Region

London

Procurement method

Open

Category

Goods

Contract starts

Not provided

Contract ends

Not provided

CPV classifications

33600000

Pharmaceutical products

Lots

Lot 3 CM/PHR/20/5606/03 - NHS Supply of Risankizumab for South of England & London

£4,659,703

Lot 3 - CM/PHR/20/5606/03 - NHS National Framework Agreement for the supply of Risankizumab for South of England and London. Period of framework: 1 March 2023 to 31 August 2023 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 6 months. Additional information: Price is not the only award criterion an...

Delivery: United Kingdom

Lot 2 CM/PHR/20/5606/02 - NHS Framework for North of England Branded - Annual Tranche

£481,274,600

CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche. Period of framework: 1 March 2023 to 29 February 2024 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months. Additional information: Price is not the only award criterion and all criteria are stated only...

Delivery: United Kingdom

Lot 1 CM/PHR/20/5606/01 - NHS Framework for North of England Branded - Tranche A

£167,719,344

Lot 1 - CM/PHR/20/5606/01 - NHS Framework for North of England Branded Medicines - Tranche A. Period of framework: 1 March 2023 to 28 February 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Additional information: Price is not the only award criterion and all criteria are stated on...

Delivery: United Kingdom

Documents

No document metadata is available for this public record.

Contains public sector information licensed under the Open Government Licence v3.0.